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OBJECTIVE—Establishing Caenorhabditis elegans as a model
for glucose toxicity–mediated life span reduction.
RESEARCH DESIGN AND METHODS—C. elegans were
maintained to achieve glucose concentrations resembling the
hyperglycemic conditions in diabetic patients. The effects of high
glucose on life span, glyoxalase-1 activity, advanced glycation
end products (AGEs), and reactive oxygen species (ROS) forma-
tion and on mitochondrial function were studied.
RESULTS—High glucose conditions reduced mean life span
from 18.5  0.4 to 16.5  0.6 days and maximum life span from
25.9  0.4 to 23.2  0.4 days, independent of glucose effects on
cuticle or bacterial metabolization of glucose. The formation of
methylglyoxal-modiﬁed mitochondrial proteins and ROS was
signiﬁcantly increased by high glucose conditions and reduced
by mitochondrial uncoupling and complex IIIQo inhibition. Over-
expression of the methylglyoxal–detoxifying enzyme glyox-
alase-1 attenuated the life-shortening effect of glucose by
reducing AGE accumulation (by 65%) and ROS formation (by
50%) and restored mean (16.5  0.6 to 20.6  0.4 days) and
maximum life span (23.2  0.4 to 27.7  2.3 days). In contrast,
inhibition of glyoxalase-1 by RNAi further reduced mean (16.5 
0.6 to 13.9  0.7 days) and maximum life span (23.2  0.4 to
20.3  1.1 days). The life span reduction by glyoxalase-1 inhibi-
tion was independent from the insulin signaling pathway because
high glucose conditions also affected daf-2 knockdown animals
in a similar manner.
CONCLUSIONS—C. elegans is a suitable model organism to
study glucose toxicity, in which high glucose conditions limit the
life span by increasing ROS formation and AGE modiﬁcation of
mitochondrial proteins in a daf-2 independent manner. Most
importantly, glucose toxicity can be prevented by improving
glyoxalase-1–dependent methylglyoxal detoxiﬁcation or prevent-
ing mitochondrial dysfunction. Diabetes 58:2450–2456, 2009
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ecause of its short life span, the relative ease in
modifying its genome, and its simple insulin
receptor system (daf-2) (1), Caenorhabditis el-
egans can be used not only to study molecular
targets affected by normal glucose concentration but also
by pathological glucose concentrations. It is likely a good
model to study mechanisms by which high glucose might
reduce life span.
Increased glycolytic ﬂux leads to formation of mito-
chondrial reactive oxygen species (ROS). In turn, ROS
formation decreases the activity of glyoxalase-1, an
enzyme detoxifying methylglyoxal. Accumulation of
methylglyoxal, a highly reactive dicarbonyl derived from
triosephosphates (2), leads to rapid protein modiﬁcation.
Methylglyoxal is an arginine-directed glycating agent and
precursor of advanced glycation end products (AGEs). It
modiﬁes proteins mainly but not exclusively on arginine
residues forming methylglyoxal-derived hydroimidazolone
(MG-H1) with formation of other minor AGE residues,
arginine-derived argpyrimidine and lysine-derived N
-(1-
carboxyethyl)lysine and methylglyoxal-derived lysine
dimer (3). Methylglyoxal-derived modiﬁcation of mito-
chondrial proteins increases mitochondrial ROS forma-
tion, thus reducing life span in C. elegans (4). The
formation of methylglyoxal-modiﬁed proteins in cells is
suppressed by the activity of the enzyme glyoxalase-1 that
catalyzes conversion of methylglyoxal, with the cofactor
glutathione, to S-D-lactoylglutathione. This is further con-
verted to d-lactate by glyoxalase-2 regenerating the gluta-
thione (5). We recently showed that with increasing age,
glyoxalase-1 activity decreased in C. elegans, leading to an
increase of methylglyoxal accumulation and oxidative
stress (4). In these settings, overexpression of a glyox-
alase-1 homologue in C. elegans decreased mitochondrial
AGE accumulation and increased life span, whereas
knockdown of the glyoxalase-1 gene increased AGE accu-
mulation and decreased life span, pointing to a depen-
dence of life span on AGE production (4).
Glucose restriction extends C. elegans life span. Recent
studies by Schultz et al. (6) using a model of impaired
glucose metabolism indicate that an increase in ROS
results in a secondary hormetic increase in stress defense,
eventually resulting in reduced net stress levels. In con-
trast, high glucose concentrations reduce life span of C.
elegans. Because an increased glycolytic ﬂux is likely to
cause a long-lasting accumulation of methylglyoxal-
derived AGEs and a steady increase in ROS formation, we
hypothesized that C. elegans cannot only be used for
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aging, but most importantly for understanding basic mech-
anisms of glucose toxicity. Therefore, we studied whether
elevation of glucose concentrations in C. elegans extracts
from 6 to 14 mmol/l (resembling the hyperglycemic con-
ditions in diabetic patients) could limit life span in C.
elegans by accumulation of methylglyoxal-derived AGEs
and impairment of mitochondrial function and whether
detoxifying methylglyoxal might prevent glucose toxicity
and mitochondrial damage.
RESEARCH DESIGN AND METHODS
C. elegans maintenance and life span assays. All nematodes were
cultivated on nematode growth medium (NGM) agar as described previously
(4) and maintained at 20°C. Strains used in this study include wild-type (N2)
and eat-2 (-) mutant (eat-2[ad465]II) provided by the Caenorhabditis Genetic
Center and glyoxalase-1 transgenic (4). Animals were maintained on living
Escherichia coli (OP50) from a standardized overnight culture with an OD of
1.5, which was added to the surface of the NGM plates. One hundred ﬁfty
microliters of a 400 mmol/l glucose solution was used to achieve a concen-
tration of 14 mmol/l in the worms. In experiments using dead bacteria, the
bacteria were killed by sonication. In experiments using a mitochondrial
uncoupler or a complex III inhibitor, C. elegans were cultivated in the
presence of 50 mol/l carbonylcyanide-p-triﬂuorormethoxyphenylhydrazone
(FCCP, Sigma-Aldrich) or 10 mol/l myxothiazol (Sigma-Aldrich), respectively.
Establishment of high glucose conditions. It was our aim to reach a
glucose concentration in a C. elegans whole-body extract of 10–15 mmol/l,
resembling the glucose concentrations in diabetic patients under poor glucose
control. Therefore, 150 l of a glucose solution of various concentrations was
added to the agar of NGM plates in the absence of C. elegans as described
above for 1, 3, 5, 10, and 15 days to deﬁne the time for reaching a steady state
of glucose in the agar. A piece of agar was then cut out of the middle of the
NGM plate and ﬂuidiﬁed using -agarase (New England Biolabs) as described
by the manufacturer. Glucose was measured using a Modular ISE 900 P 800
analyzer (Hitachi) according to the manufacturer’s recommendations.
Wild-type C. elegans were kept for 5 days under various glucose concen-
trations in the agar prepared as described above, harvested, and washed. An
extract of C. elegans was prepared by sonication and analyzed for the glucose
concentration using a Modular ISE 900 P 800 analyzer (Hitachi). For all further
experiments, a glucose concentration of 40 mmol/l in the agar was used
because it resulted in a glucose concentration of 14 mmol/l in the C. elegans
whole-body extract.
Scanning electron microscopy. Wild-type C. elegans were kept under high
glucose conditions for 16 days as described above. Worms were then
harvested, washed with PBS buffer, and incubated with 2.5% glutaraldehyde
overnight. After three times washing with PBS buffer, worms were transferred
into microporous specimen capsules and dehydrated in graded ethanol
solutions. Specimen were ﬁnally dried in a critical point dryer (030 Critical
point dryer, Bal-Tec) and placed onto conductive sticky tape. Subsequently,
samples were sputter coated with a 15-nm gold layer (MED020, Bal-Tec) and
imaged in a ﬁeld emission scanning electron microscope (Leo1530 Gemini).
Glyoxalase-1 activity. Glyoxalase-1 activity was assayed as described
(4,7,8). For the conversion of hemithioacetal to S-D-lactoylglutathione, the
change in molar extinction coefﬁcient, ε 240  2.86 mmol  l
1  cm
1, was
measured after the addition of the C. elegans protein extract to hemithioac-
etal, prepared by preincubating methylglyoxal and glutathione. The initial rate
of change of absorbance (A240, o [arbitrary unit, AU] min
1) was deduced,
and the A240, o for the blank value was corrected. The activity of glyoxalase-1
aGI is given in units where 1 unit of glyoxalase-1 activity catalyzes the
formation of 1 mol S-D-lactoylglutathione per minute under assay conditions.
The standard assay mixture contained 2 mmol/l methylglyoxal and 2 mmol/l
glutathione in a sodium phosphate buffer (100 mmol/l, pH 6.6, 37°C).
Staining of mitochondria and MG-H1. Staining of mitochondria for MG-H1
and confocal microscopy were performed as described (4). Brieﬂy, mitochon-
dria were stained by incubation with 50 mol/l MitoTracker Deep Red FM
(Molecular Probes) according to the manufacturer’s protocol. MG-H1 was
detected using a mouse antibody and visualized by a Texas Red-labeled rabbit
anti-mouse second antibody (Biozol) as described previously (4). Immunhis-
tology was performed according to the protocol of Ruvkun (for details see
http://www.wormatlas.org/anatmeth/ﬁnneyruvkun.pdf). Formation and colo-
calization of MG-H1 with mitochondria was quantiﬁed by using the image
processing and analysis software ImageJ (10) with the Intensity Correlation
Analysis plug-in (11) as described previously (4).
Staining of ROS. Staining of ROS, confocal microscopy, and analysis with
ImageJ were performed as described previously (4). Brieﬂy, C. elegans were
washed, incubated with 3 mol/l of dihydroethidium for 30 min, and analyzed
for ﬂuorescence intensity by confocal microscopy. Raw data from confocal
microscopy were then analyzed using ImageJ.
RNAi. For RNAi experiments, the feeding technique was used as described
previously (4,12,13). Individual colonies of E. coli HT115 containing plasmids
of interest (Y55D5A.5 [daf-2] and C16C10.10 [glyoxalase-1]) were inoculated in
LB broth containing ampicillin (100 mg/ml) (Sigma-Aldrich, Mu ¨nchen, Ger-
many) and grown overnight at 37°C. Bacteria (150 l) were then seeded onto
NGM plates containing carbenicillin (0.025 g/l) and isopropyl--D-thiogalacto-
pyranoside (IPTG) (0.25 g/l) and allowed to dry overnight. E. coli containing
only the control vector were grown in parallel and seeded on control plates.
Twenty L4 stage hermaphrodites (one generation) were placed on each
plate and incubated overnight at 20°C. The worms were then transferred on a
fresh RNAi plate, and left to lay eggs for 24 h. The old worms were removed
from the plates, and the eggs were incubated at 20°C until worms were in L4
stage. These worms were used for life span observation. Furthermore, to use
active RNAi E. coli and to prevent mixture of generations, worms were
transferred by picking on a new NGM-IPTG/carbenicillin plate seeded with the
appropriate E. coli clone every day.
Determination of life span. Age-synchronized worms were obtained as
described before (4). Life span studies without RNAi were performed as
described (4,9) on NGM plates containing 300 g/ml 5-ﬂuorodesoxyuridine
(Sigma-Aldrich) to prevent progeny production. Life span studies using RNAi
were performed on NGM plates containing carbenicillin (0.025 g/l) and IPTG
(0.25 g/l), and animals were transferred to new plates daily. In all experiments,
the prefertile period of adulthood was used as t  0 for life span analysis.
Animals that did not move after repeated stimulus were regarded as dead.
Animals that crawled away from the plate or contained internally hatched
worms were excluded. One hundred worms were used for each experiment;
all experiments were performed at least three times.
Statistical analysis. Statistical analysis was performed using StatView 5.0
software (SAS Institute, Cary, NC). In experiments in which only two groups
were compared (Figs. 1–5), unpaired t tests were used to determine signiﬁ-
cance. If multiple groups were run (Table 1 and Fig. 6), the data were
compared across the groups using ANOVA; additional between-group com-
parisons were made using Fisher protected least signiﬁcant difference (PLSD)
post hoc tests.
RESULTS
To establish the potential rate of diffusion of glucose from
the medium to the agar, a solution of glucose (400 mmol/l)
was added to an agar plate and incubated for a period of 15
days. At consecutive time points, glucose concentration
was determined. No signiﬁcant change in glucose concen-
tration was observed in the agar (data not shown). In all
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FIG. 1. Glucose concentration in C. elegans. C. elegans were cultured
on agar having the glucose concentrations of 0, 10, 20, 30, 40, and 50
mmol/l. After 5 days, 100 C. elegans were harvested and the glucose
concentrations in the C. elegans whole-body extracts were deter-
mined. Results are the means  SE of three independent experiments;
n.s. (not signiﬁcant) describes a t test value (P > 0.05, *P < 0.05, and
***P < 0.001) comparing two groups as indicated.
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least 1 day with an appropriate concentration of glucose
before inoculation with C. elegans.
C. elegans (ca. 100) were cultured on agar plates con-
taining various concentrations of glucose (0 to 50 mmol/l)
for 5 days. After which time, intracellular glucose concen-
trations were determined from whole-body extracts. It
was found that culturing of C. elegans on agar plates
containing 40 mmol/l glucose resulted in an intracellular
concentration of 14 mmol/l (Fig. 1), which is within the
range observed in poorly controlled diabetic patients. In
all subsequent experiments, C. elegans cultured under
high glucose conditions refer to a concentration of 40
mmol/l, whereas standard conditions refer to no additional
glucose being added to the agar.
Under high glucose conditions, mean life span was
reduced from 18.5  0.4 to 16.5  0.6 days (P  0.05), and
maximum life span was reduced from 25.9  0.4 to 23.2 
0.4 days (P  0.05) (Fig. 2 and Table 1). Scanning electron
microscopy studies excluded nonspeciﬁc high glucose
effects on the cuticle of the worms because there was no
morphological difference in the appearance of C. elegans
held under high glucose conditions for 16 days and the
control group (data not shown). To exclude nonspeciﬁc
osmotic effects, experiments were performed by adding
sorbitol as control. Sorbitol affected neither mean (P 
0.05) nor maximum (P  0.05) life span (Table 1). To
exclude nonspeciﬁc effects because of bacterial metabo-
lization of glucose, control experiments were performed
using dead bacteria. In these experiments, the addition of
glucose reduced mean life span from 29.3  0.1 to 25.1 
0.1 days (P  0.01) and maximum life span from 40.5  2.5
to 35.5  0.5 days (P  0.05) (Table 1). The increased life
span compared to animals fed with living bacteria could be
caused by caloric restriction because of differential food
preferences. These results point to a speciﬁc life-
shortening effect of glucose. Thus, increasing the total
body glucose concentration to 14 mmol/l resulted in a
reduction of life span not explained by nonspeciﬁc effects.
Glyoxalase-1 is central in controlling the extent of
methylglyoxal and methylglyoxal-derived AGE formation
because of glucose metabolism. After high glucose expo-
sure for 5 days, glyoxalase-1 activity determined in whole-
body extracts of C. elegans was reduced from 0.368 
0.004 to 0.211  0.025 mU/g protein, whereas sorbitol
had no signiﬁcant effect (Fig. 3).
To test whether glucose-dependent glyoxalase-1 down-
regulation leads to an increase in AGE modiﬁcation of
mitochondria in C. elegans (4,14), the level of MG-H1 was
determined using immunostaining. The staining of MG-H1
in standard (Fig. 4B) and high-glucose animals (Fig. 4E)
did not differ with respect to localization, only with
respect to the intensity. When mitochondria were stained
with MitoTracker and counterstained for MG-H1, colocal-
ization of MG-H1 with mitochondria could be detected
(Fig. 4C and F). Because of the higher content of MG-H1,
staining for colocalization was stronger under high glu-
cose than standard glucose conditions.
Previously, we reported a C. elegans strain with trans-
genic stable overexpression of glyoxalase-1 (4). This re-
sulted in a 	200-fold increase of glyoxalase-1 activity (4).
These animals with genetically controlled stable
glyoxalase-1 expression were also exposed to standard
and high glucose conditions. Overexpression of C. elegans
glyoxalase-1 (4) resulted in a decrease in total and mito-
chondrial MG-H1 in standard (Fig. 4H and I) as well as in
high glucose (Fig. 4K and L) conditions.
The increase of mitochondrial immunoreactive MG-H1
was paralleled by an increase in ROS formation (Fig.
5A–D). When dihydroethidium staining was used to visu-
alize ROS generation, a strong increase was seen in C.
elegans cultured for 15 days in high glucose (Fig. 5B)
compared to standard conditions (Fig. 5A). Using trans-
genic C. elegans overexpressing glyoxalase-1, a dramatic
reduction in dihydroethidium staining was observed. Un-
der standard conditions, transgenic C. elegans had a
staining signiﬁcantly below control (Fig. 5A and C) and
even under high glucose conditions, overexpression of
glyoxalase-1 reduced staining below wild-type controls
(Fig. 5B and D).
To test whether high glucose-induced mitochondrial
dysfunction is responsible for increased MG-H1 and ROS
formation, experiments were repeated with C. elegans
cultured in the presence of the electron transport chain
uncoupler FCCP (50 mol/l) or the complex IIIQo inhibi-
tor myxothiazol (10 mol/l) for 15 days (Fig. 6A and B).
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FIG. 2. Effect of high glucose conditions on C. elegans life span.
Kaplan-Meier graphs of the fraction of C. elegans alive. Shown are
wild-type C. elegans cultured under standard and high glucose condi-
tions. Life span assays were performed as described in RESEARCH
DESIGNS AND METHODS. The results are from a representative experiment
out of three independent experiments, each including 100 nematodes.
Thin line  standard conditions; bold line  high glucose conditions.
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FIG. 3. Effect of high glucose conditions on glyoxalase-1 activity.
Quantiﬁcation of glyoxalase-1 activity in whole-body extracts of 5-day-
old wild-type (WT) animals, cultured under standard and high glucose
conditions, or sorbitol as control. Results are the means  SE of three
independent experiments; value from a t test (***P < 0.001) comparing
wild type under standard conditions vs. wild type under high glucose
conditions.
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a signiﬁcant increase from 93  4t o1 4 2 12 (P  0.001)
was observed in worms treated with high glucose for 15
days (Fig. 6A). MG-H1 formation in high glucose wild-type
C. elegans was signiﬁcantly reduced by FCCP and myx-
othiazol. FCCP and myxothiazol reduced MG-H1 forma-
tion in standard and high glucose–treated animals to the
same level, which was by 	49% of staining observed in
wild type under standard conditions and by 	66% com-
pared to high glucose (Fig. 6A).
A similar result was observed with ROS formation.
When AUs/pixel were used to quantify ROS generation, a
signiﬁcant increase from 45  6t o8 8 4( P  0.001) was
observed in worms treated with high glucose for 15 days
(Fig. 6B). FCCP and myxothiazol reduced ROS formation
by 36% in standard and up to 62% in high glucose cultured
C. elegans (Fig. 6B). Thus, overcoming high glucose–
induced mitochondrial dysfunction reduces MG-H1 and
ROS formation.
Treatment with either FCCP or myxothiazol enhanced
life span under both conditions (Table 1). FCCP increased
mean life span from 18.5  0.4 to 21.7  1.7 days (P 
0.05) and maximum life span from 25.9  0.4 to 31.5  0.5
days (P  0.01), whereas myxothiazol increased mean life
span from 18.5  0.4 to 21.1  1.1 days (P  0.01) and
maximum life span from 25.9  0.4 to 31.0  1.7 days (P 
0.01) under standard glucose conditions (Table 1). Under
high glucose conditions, FCCP increased mean life span
from 16.5  0.6 to 19.5  0.9 days (P  0.05) and maximum
life span from 23.2  0.4 to 28.5  1.5 days (P  0.01),
whereas myxothiazol increased mean life span from
16.5  0.6 to 20.4  0.1 days (P  0.001) and maximum life
span from 23.2  0.4 to 27.7  1.9 days (P  0.01).
To determine whether overexpression of glyoxalase-1
cannot only reduce MG-H1 (Figs. 4 and 6A) and ROS (Figs.
5 and 6B) formation, but also counteract the life shorten-
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FIG. 4. Mitochondrial MG-H1 immunoreactivity in C. elegans. Mitochondria were stained with MitoTracker Deep Red FM (A, D, G, and J), and
MG-H1 was visualized by immunostaining with a Texas Red-labeled antibody directed against MG-H1 antibody (B, E, H, and K). Merged staining
is shown in C, F, I, and L. Orange color indicates colocalization of MG-H1 with mitochondria. Images are shown for 15-day-old wild-type animals
cultured under standard (A–C) and high glucose conditions (D–F) and 15-day-old transgenic glyoxalase-1–overexpressing animals cultured under
standard (G–I) and high glucose conditions (J–L). Shown are animals from a representative experiment out of three independent experiments,
each including 100 nematodes.
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FIG. 5. Effect of high glucose conditions on formation of ROS. Shown
are ethidium-labeled wild-type animals cultured for 15 days under
standard (A) and high glucose conditions (B), transgenic glyoxalase-1–
overexpressing animals cultured for 15 days under standard (C) and
high glucose conditions (D). Shown are animals from a representative
experiment out of three independent experiments, each including 100
nematodes.
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were exposed to glucose (Table 1). Overexpression of
glyoxalase-1 prolonged mean life span in standard culture
conditions from 18.5  0.4 in wild type to 20.3  0.2 in
transgenic (P  0.05) and maximum life span from 25.9 
0.4 to 29.2  1.5 days (P  0.05). Under high glucose
conditions, mean life span of 16.5  0.6 days in wild type
was increased to 20.6  0.4 days in transgenic animals
(P  0.001) and maximum life span of 23.2  0.4 to 27.7 
2.3 days (P  0.01), thus restoring life span under high
glucose conditions to the life span seen in wild type under
standard glucose concentration (Table 1).
In contrast, a decrease of life span under standard
glucose conditions was seen when RNAi was used to
knockdown glyoxalase-1 activity by 75% (4). Under normal
glucose conditions mean life span of 18.5  0.4 days in
wild type was reduced by glyoxalase-1 RNAi to 13.5  1.2
days (P  0.001). Maximum life span was reduced from
25.9  0.4 to 21.0  1.2 days (P  0.01). In the presence of
high glucose, mean life span was reduced from 16.5  0.6
in wild type to 13.9  0.7 in glyoxalase-1 RNAi treated C.
elegans (P  0.01) and maximum life span from 23.2  0.4
to 20.3  1.1 days (P  0.05) (Table 1).
The reduction of life span under high glucose conditions
is independent from the pathways activated by caloric
restriction because the effect of glucose was still observed
in eat-2 (-) mutants with reduced pharyngeal activity and
thus reduced caloric uptake (Table 1). In eat-2 mutants,
mean life span was reduced from 24.3  0.3 days in
standard culture conditions to 21.5  1.4 days in high
glucose conditions (P  0.05) and the maximum life span
from 33.3  0.3 to 29.0  1.5 days (P  0.05). Thus, the
proportional reduction of mean and maximum life span is
12 and 13% in eat-2 mutants, respectively. Both correspond
well to a reduction of mean life span of 11% and a
reduction of maximum life span of 10% by high glucose in
wild-type C. elegans. Thus, the glycotoxic effects de-
scribed here are independent from the eat-2 controlled
starvation pathway.
A decline in daf-2 insulin signaling pathway of C. elegans
(1) is known to result in activation of the fork-like tran-
scription factor daf-16 and to prolong life span (9). This
effect, however, was also observed to be diminished under
high glucose conditions. Administration of glucose to C.
elegans knockdown for daf-2 by RNAi had similar effects
as in wild-type worms, namely, a reduction of mean life
span from 24.2  2.0 to 20.6  1.7 days (P  0.05) and
maximum life span from 35.0  3.0 to 30.0  2.0 days (P 
0.05) (Table 1). This points to a life span–reducing mech-
anism under high glucose conditions, which is indepen-
dent from the eat-2 and daf-2/daf-16 pathway and
dependent on glyoxalase-1–controlled mitochondrial com-
plexes II and III (Table 1).
DISCUSSION
The major purpose of the study was to establish C. elegans
as a model for diabetes research to understand basic
mechanisms underlying glucose effects on cellular and
mitochondrial function. Because a total body glucose
concentration of 14 mmol/l was sufﬁcient to achieve
signiﬁcant effects on life span, this in vivo model organism
provides a reliable tool to decipher changes in cellular
functions induced by glucose concentrations that are
within the range observed in poorly controlled diabetic
patients.
As shown here, long-lasting high glucose conditions
result in a permanent accumulation of methylglyoxal-
derived modiﬁcations of mitochondrial proteins, a steady
increase in ROS formation and a signiﬁcant reduction in
life span. These effects are independent of osmotic pres-
sure, the pathways activated by caloric restriction in eat-2
mutants, and the insulin-like receptor daf-2/daf-16 path-
way, one of the central pathways involved in life span
TABLE 1
Summary of individual life span experiments
Mean life span
in days  SE
Max life span
in days  SE
P value vs. speciﬁc group
Mean life
span
Max
life span
WT (standard) 18.5  0.4 25.9  0.4
WT (high glucose) 16.5  0.6 23.2  0.4 0.05
a 0.05
a
WT 
 sorbitol 17.9  0.2 24.5  0.5 n.s. (0.6438)
a n.s. (0.4676)
a
Glyoxalase-1 transgenic 20.3  0.2 29.2  1.5 0.05
a 0.05
a
Glyoxalase-1 transgenic (high glucose) 20.6  0.4 27.7  2.3 0.001
b 0.01
b
WT 
 glyoxalase-1 RNAi 13.5  1.2 21.0  1.2 0.001
a 0.01
a
WT 
 glyoxalase-1 RNAi (high
glucose) 13.9  0.7 20.3  1.1 0.01
b 0.05
b
WT 
 dead bacteria 29.3  0.1 40.5  2.5
WT 
 dead bacteria (high glucose) 25.1  0.1 35.5  0.5 0.01
c 0.05
c
eat-2 (-) mutant 24.3  0.3 33.3  0.3
eat-2 (-) mutant (high glucose) 21.5  1.4 29.0  1.5 0.05
c 0.05
c
WT 
 daf-2 RNAi 24.2  2.0 35.0  3.0
WT 
 daf-2 RNAi (high glucose) 20.6  1.7 30.0  2.0 0.05
c 0.05
c
WT 
 FCCP 21.7  1.7 31.5  0.5 0.05
a 0.01
a
WT 
 FCCP (high glucose) 19.5  0.9 28.5  1.5 0.05
b 0.01
b
WT 
 myxothiazol 21.1  1.1 31.0  1.7 0.01
a 0.01
a
WT 
 myxothiazol (high glucose) 20.4  0.1 27.7  1.9 0.001
b 0.01
b
Summary of mean and maximum (max) life span and statistical analysis for life span experiments. The data were compared across the groups
using ANOVA; additional between-group comparisons were made using Fisher PLSD post hoc tests. P value from a Fisher PLSD post hoc test
comparing a group vs. (a) wild type (WT) under standard conditions, (b) WT under high glucose conditions, or (c) the corresponding group
under standard conditions.
GLUCOSE REGULATES LIFE SPAN IN C. ELEGANS
2454 DIABETES, VOL. 58, NOVEMBER 2009 diabetes.diabetesjournals.orgdetermination. Because overexpression of the C. elegans
homologue of glyoxalase-1 partly reversed these speciﬁc
glucose effects, while knockdown of glyoxalase-1 further
shortened the life span, protective enzymes capable of
reducing reactive metabolites generated by high glucose,
do not only normalize the function of single cells but
determine the life span of a whole organism.
In a recent study, Schulz et al. (6) analyzed life span
extension in C. elegans by glucose restriction. It was
concluded that impairment of glucose metabolism initially
causes enhanced mitochondrial respiration and increased
ROS formation resulting in a short-lasting and nonlethal
stress, leading to a secondary and long-lasting increase in
antioxidant defenses. Therefore, glucose restriction in-
creases C. elegans life span by hormetic sustained reduction
of net stress levels. This ﬁts well to the previously established
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FIG. 6. Quantiﬁcation of MG-H1 and ROS in C. elegans. Formation of MG-H1 (A) and ROS (B) was quantiﬁed in 15-day-old wild-type (WT)
animals, without and with 10 mol/l myxothiazol (myxo) or 50 mol/l FCCP, and in 15-day-old transgenic glyoxalase-1–overexpressing animals.
Each group was cultured under standard and high glucose conditions. The data were compared across the groups using ANOVA; additional
between-group comparisons were made using Fisher PLSD post hoc tests. Results are the means  SE of three independent experiments with 100
nematodes each; value from a Fisher PLSD post hoc test (*P < 0.05 and ***P < 0.001) comparing the indicated group vs. wild type under standard
conditions; value from a Fisher PLSD post hoc test (
oooP < 0.001) comparing the indicated group vs. wild type under high glucose conditions.
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and thereby providing tools for prolonging life span. Another
study shows that mitochondria of long-lived daf-2 mutants
produce increased amounts of ROS compared to wild-type
mitochondria (15), probably because daf-2 mutants show a
higher antioxidant activity by upregulation of antioxidant
enzymes (16–18). Up to now, however, it is not known
whether these life-enhancing effects of such a glucose restric-
tion would still be evident under conditions with high extra-
cellular glucose concentrations.
Additional studies are needed to analyze whether the
changes in life span observed by glucose administration or
restriction are mainly depending on extracellular or intra-
cellular effects. Our data suggest that the excess of a
certain glucose level leads to an overload and subsequent
inhibition of the glyoxalase-1 system. A potential explana-
tion is that the long-lasting high glucose conditions used
here result in a sustained excess of ROS, depleting glyox-
alase-1, which in turn might result in a breakdown of the
mitochondrial integrity by methylglyoxal-dependent pro-
tein modiﬁcation and ultimatively ends in increased ROS
formation and life span reduction (4).
Future studies are required to prove whether mecha-
nisms described in C. elegans can be translated to the
situation in diabetic patients. Although total life span is an
emerging goal of diabetes treatment, it is evident that
simply lowering glucose concentrations is not sufﬁcient to
normalize life expectancy in patients with diabetes (19).
The availability of an in vivo model of life expectancy
might open new opportunities to study cellular defense
systems such as glyoxalase-1 in the context of high glu-
cose and total life span. Thus, protecting glyoxalase-1
activity from glucose-dependent downregulation might
provide a promising therapeutic option in increasing the
life expectancy in diabetic patients.
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